Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that the NHS is only paying a reasonable price for drugs.
The National Institute for Health and Care Excellence is the independent body responsible for developing evidence-based recommendations for the National Health Service on whether new medicines represent an effective use of resources based on their clinical and cost-effectiveness.
The costs of branded medicines are controlled by the 2019 Voluntary Scheme for Branded Medicines Pricing and Access and the statutory scheme for branded medicines.